Difficulty: Medium
Average Score: 84%
Practice
Modest improvement in the memory of patients with Alzheimer's disease may occur with drugs that increase transmission at which of the following receptors?
Correct answer
B
Rationale
Alzheimer's disease features cholinergic neuron loss, impairing memory via reduced acetylcholine signaling in the hippocampus and cortex. Drugs like acetylcholinesterase inhibitors (e.g., donepezil) boost cholinergic transmission by preventing acetylcholine breakdown, modestly improving memory and cognition in early stages. Adrenergic enhancement (e.g., via norepinephrine) affects arousal, not memory directly. Dopaminergic drugs treat Parkinson's, not Alzheimer's cognitive deficits. GABAergic drugs (e.g., benzodiazepines) inhibit cognition, worsening memory. Serotonergic agents target mood, not memory. The cholinergic deficit is a hallmark of Alzheimer's pathology, and augmenting this system remains a primary therapeutic strategy, validated by clinical outcomes.